The origin of Rosenthal fibers and their contributions to astrocyte pathology in Alexander disease
© The Author(s). 2017
Received: 19 January 2017
Accepted: 8 March 2017
Published: 31 March 2017
Rosenthal fibers (RFs) are cytoplasmic, proteinaceous aggregates. They are the pathognomonic feature of the astrocyte pathology in Alexander Disease (AxD), a neurodegenerative disorder caused by heterozygous mutations in the GFAP gene, encoding glial fibrillary acidic protein (GFAP). Although RFs have been known for many years their origin and significance remain elusive issues. We have used mouse models of AxD based on the overexpression of human GFAP (transgenic, TG) and a point mutation in mouse GFAP (knock-in, KI) to examine the formation of RFs and to find astrocyte changes that correlate with the appearance of RFs. We found RFs of various sizes and shapes. The smallest ones appear as granular depositions on intermediate filaments. These contain GFAP and the small heat shock protein, alphaB-crystallin. Their aggregation appears to give rise to large RFs. The appearance of new RFs and the growth of previously formed RFs occur over time. We determined that DAPI is a reliable marker of RFs and in parallel with Fluoro-Jade B (FJB) staining defined a high variability in the appearance of RFs, even in neighboring astrocytes. Although many astrocytes in AxD with increased levels of GFAP and with or without RFs change their phenotype, only some cells with large numbers of RFs show a profound reconstruction of cellular processes, with a loss of fine distal processes and the appearance of large, lobulated nuclei, likely due to arrested mitosis. We conclude that 1) RFs appear to originate as small, osmiophilic masses containing both GFAP and alphaB-crystallin deposited on bundles of intermediate filaments. 2) RFs continue to form within AxD astrocytes over time. 3) DAPI is a reliable marker for RFs and can be used with immunolabeling. 4) RFs appear to interfere with the successful completion of astrocyte mitosis and cell division.
KeywordsRosenthal fibers Alexander disease Astrocytes GFAP alphaB-crystallin
Rosenthal fibers (RFs) are distinctly characteristic features of the astrocyte pathology in Alexander Disease (AxD), a neurodegenerative disorder caused by heterozygous mutations in the gene encoding glial fibrillary acidic protein (GFAP), the major intermediate filament in astrocytes [15, 21]. RFs are protein aggregates in the cytoplasm of astrocytes. They were originally identified by inspection with the light microscope as bright, eosinophilic profiles inside astrocytes. Ultrastructurally, RFs appear as amorphous, electron dense material, surrounded by skeins of intermediate filaments, and are not membrane bound [1, 10, 19, 23]. RFs are composed mainly of intermediate filaments, GFAP , vimentin, and synemin  in addition to other proteins including the small heat shock proteins alphaB-crystallin  and Hsp 27 , the filament binding protein plectin , and Cyclin D2 .
Although RFs are characteristic of AxD, they are not unique to this disease. For example, RFs are regularly found in pilocytic astrocytomas and chronic astrocyte scars [4, 11, 26]. Occasionally astrocytes in other disorders, such as cortical dysplasias and tuberous sclerosis, contain RFs [13, 14]. Presumably the common denominator is the accumulation of very large amounts of GFAP inside the astrocyte . RFs vary substantially in size, from very large to small, the latter appearing at the light microscope level as a cytoplasmic, eosinophilic granularity.
Many neuropathologists have shown electron micrographs of RFs, but there is still little known about the formation of these inclusions. To gain insights into this question, we analyzed RFs during the progression of AxD in mouse models. We have used four murine models of AxD: 1) one based on the insertion of additional copies of human GFAP (transgenic AxD mice, TG); 2) one based on replacement of one copy of GFAP with a mutant (R236H mutation, the mouse homolog of the most common human AxD mutation) mouse GFAP (heterozygous knock-in AxD mice, heterozygous KI); 3) homozygous knock-in (KI) AxD mice, with replacement of both copies of GFAP with R236H mutant mouse GFAP; 4) the offspring of transgenic (TG) and homozygous knock-in (KI) mice (double mutant) [7, 16]. The latter are severely affected, dying within 5 weeks with seizures . All of these mice are characterized by an abundance of RFs. We performed electron microscopic examinations of RFs and found evidence that RFs form from small accumulations of electron dense material, containing GFAP and alphaB-crystallin, on intermediate filaments. These small RFs appear to merge with the edges of larger RFs. We also found that in addition to Fluoro-Jade B that DAPI staining is a sensitive marker of RFs, one that can be combined with immunofluorescence.
Material and methods
The TG and KI AxD murine models have been introduced and previous described [5, 15]. These mice could survive for more than 1 year without features of illness or fatigue. Cross breeding of TG and KI produce mice that survive about 1 month and die after severe seizures. The TG line was initially generated in an FVB background, but the mice were crossed into a B6 background over at least five generations before they were used for these experiments. The KI line was initially generated in mice with a B6 background but now is maintained on a mixed 129S6 x FVB/N strain. Only male mice were used in the experiments. In total we used 9 double mutant (3 at the age of 1 week and 6 at the age of 1 month), 10 TG (4 at the age of 1 month and 6 at the age of 1 year), and 14 KI (homozygous, 2 at the age of 1 month and 5 at the age of 1 year; heterozygous, 2 at the age of 1 month and 4 at the age of 1 year). All animal use was performed under the guidelines of the Columbia University Institutional Animal Care and Use Committee.
Autopsy tissue (fixed in formalin and embedded in paraffin) from two (F, 11 month of age and F, 3 years old) AxD patients was used for analysis. Diagnosis was confirmed by histopathological examination and genetic analysis for GFAP mutations. Postmortem intervals were less than 10 h.
Histology and immunohistochemistry
Mice were anesthetized with ketamine-xylazine before intracardiac perfusion with 4% paraformaldehyde in PBS. Brains were removed and kept in the fixative for 12 - 16 h (40 C). Forty μm coronal sections were prepared with a vibratome (Leica VT1000S) and stored in cryoprotectant solution at -200 C before use. Paraffin sections from the blocks of autopsy AxD human brains were deparaffinized and were used for immunostaining. Some were stained with H&E.
Primary antibodies were used against: (i) glial fibrillary acidic protein (GFAP): mouse monoclonal (1:1000, G3893, Sigma-Aldrich, St. Louis, MO), rabbit polyclonal (1:1000, Z 0334, Dako, Carpinteria, CA); (ii) CD44: rat monoclonal (1:200, #217594, Millipore); (iii) Ki67: mouse monoclonal (1:100, #550609, BD Pharmingen, San Jose, CA); (iv) a centrosome marker, pericentrin: rabbit polyclonal (1:400, PRB-432C, Covance). Secondary antibodies included: anti-mouse Alexa Fluor 488 and 594; anti-rabbit Alexa Fluor 488 and 594; anti-rat Alexa Fluor 488 and 594; all from goat or donkey (1:300, Molecular Probes, Eugene, OR).
For immunofluorescence, after blocking with 10% normal goat (or donkey) serum (30 min, at room temperature (RT)), free-floating sections were incubated in a mixture of primary antibodies raised in different species for overnight (40 C). For visualization, Alexa Fluor-conjugated secondary antibodies were applied for 1 h at RT. For visualization of nuclei Fluorescent Nissl reagent (NeuroTrace 640/660 deep-red, 1:150, Molecular Probes, 30 min after secondary antibodies, RT) and DAPI (5 μg/ml; D9542, Sigma-Aldrich, added to secondary antibodies for the last 10 min of incubation) were used. Paraffin sections and mouse brain sections were treated with Antigen Unmasking Solution (Vector Laboratories, # H-3300, Burlingame, CA) according to manufacturer’s recommendations before blocking with serum. Blocking serum, primary, secondary antibodies, and DAPI were applied in 0.2% Triton X-100 in PBS. Sections for fluorescent microscopy were mounted on slides in Vectashield (Vector Lab). To control for the specificity of immunostaining, primary antibodies were omitted and substituted with appropriate normal serum. Slides were viewed using a Nikon A1R MP confocal microscope. 3D reconstructions were generated from stacks of images with confocal microscope software NIS-Elements.
Fluoro-Jade B Staining was performed according to manufacturer’s recommendations (Millipore). Briefly, 40 μm coronal brain slices were mounted on the slides, dried, exposed to 1% NaOH in 80% alcohol for 5 min, followed by 70% alcohol (2 min) and distilled water (2 min). After pretreatment in 0.006% potassium permanganate (15 min RT) followed by washing (distilled water, 2 min), slides were incubated in 0.0004% of FluoroJade B (in distilled water with 0.1% acetic acid) for 20 min (RT) and after drying were coverslipped with DPX (Sigma-Aldrich). This method was initially proposed and is widely used for the detection of degenerating neurons . Reactive astrocytes  and Rosenthal fibers  were also stained with Fluoro Jade B.
Electron microscopy (EM)
For regular transmission EM vibratome slices were additionally fixed in 2.5% glutaraldehyde in PBS (several hrs at 4 °C), postfixed in 2% osmium tetroxide in 0.2 PBS (2 h at 4 °C), dehydrated and flat-embedded in Epon-Araldite (Electron Microscopy Sciences, Hatfield, PA) on ACLAR Embedding Film (Ted Pella, Inc., Redding, CA). Areas of interest were identified under light microscope, cut from sections, and glued onto resin blocks. Ultrathin sections were cut with Reichert Ultracut E, stained with uranyl acetate and lead citrate, and examined with a JEOL 1200 electron microscope.
For postembedding immunogold immunocytochemistry small pieces of the neocortex and hippocampus were embedded in LR White Resin (Berkshire, England). Ultrathin sections on nickel grids were blocked with 10% donkey serum (30 min, RT), incubated with primary antibodies anti-GFAP (rabbit polyclonal, 1:200, Dako, for single staining, and mouse monoclonal, Sigma, 1:100), for double immunostaining with anti-alphaB-crystallin (rabbit polyclonal, 1:100, Millipore) applied overnight at 40 C, followed by secondary antibodies conjugated with gold particles (12 nm in diameter for GFAP, and 18 nm for alphaB-crystallin) (all at 1:50) for 1.5 h at RT. Blocking donkey serum, primary and secondary antibodies were applied in PBS and grids were put on the top of droplets of corresponding solutions. Ultrathin sections were stained with uranyl acetate and examined with a JEOL 1200 electron microscope.
The numbers of RFs and the area they occupied were counted in the images (merged from stacks of 6 adjacent images with 1024 × 1024 pixel resolution, observed area 295 × 295 μm, captured by confocal microscopy at a distance of 0.5 μm from each other) obtained from neocortices in coronal sections stained with Fluoro-Jade B (10 images from each section, 5 sections per animal). Images were transferred to Image J 1.46r (public domain), grayscaled and quantified based on the optical density (OD). The size of small RFs, detected with the electron microscope, and the numbers of RFs with different shapes were determined in EM images. We counted RFs in all parts of astrocytes, including cell bodies, processes, and endfeet.
Data were expressed as mean ± SEM. Student’s t-test was used as appropriate for parametric data. For non-parametric data Chi-square test was used. P <0.05 was considered significant.
RFs appear to form from small aggregates
We found that some of the large profiles of electron-dense material were enclosed by double membranes, suggesting that these were enfolded by autophagic vacuoles (Fig. 3b). It was only the homogeneous material with high electron density that was surrounded by membranes.
Variability in the shapes and sizes of RFs
The variability in the ultrastructure of RFs was a characteristic feature of all 4 types of murine AxD models and many forms of RFs could be found in each line, although some forms of RFs might be considered characteristic. We paid special attention to comparing the TG and KI mice because these lines clearly represent different alterations in GFAP composition. Thus, RFs shown in Fig. 1c were observed only in KI mice. RFs in form of undulated ramified bands of electron dense material shown in Fig.1c and Additional file 1: Figure S1C predominated in KI mice and constituted 54% of all RFs in KI homozygous mice vs 20% in TG mice (P <0.001, Chi-Square test).
Despite the high degree of variability of shapes and sizes of RFs, it was possible to discriminate three main types: 1) large RFs with an oval to round shape and a size more than 0.4 μm in diameter/width (Fig. 1a, c, e; Additional file 1: Figure S1b, D), 2) elongated RFs (several μm in length and with widths of 0.3–0.5 μm) (Fig. 1b), 3) small RFs (less than 0.4 μm in width) with puncta-like (Fig. 2a, b and c; Additional file 2: Figure S4c, astrocyte 2) or ramified, ribbon-like (Fig. 1c, Additional file 1: Figure S1c) shapes. Combinations of these types could be present even in one astrocyte and neighboring astrocytes often differed in the size and shape of RFs. The maximal size of RFs appeared to be limited and did not surpass ~ 9 μm in the long axis.
DAPI is a reliable marker for RFs
Staining with FJB and DAPI revealed that RFs predominated in the areas with high levels of astrogliosis and in the neocortex they were found in abundance in upper cortical layers (Fig. 5). The largest numbers of RFs were found in the double mutant and the TG mice. The central DAPI+ part of RFs was usually GFAP immunonegative (Figs. 5d; 6a1 and b1). In ultrathin sections with immunogold post-embedding labeling, the osmiophilic material of every large RF examined near the pia and near blood vessels was heavily labeled with gold particles indicating the presence of GFAP (Fig. 4c). Such a discrepancy in immunostaining at the light and electron microscopic levels may be explained by absorption of anti-GFAP antibodies by densely packed GFAP filaments surrounding RFs and the inability of antibodies to penetrate into the dense central matrix of RFs. Antigens are far more accessible in the ultrathin sections used in electron microscopy .
In line with previous studies , we observed that FJB stained cell bodies and processes of reactive astrocytes filled with GFAP. Such properties of FJB staining, in parallel with DAPI staining, allowed us to show that astrocytes with RFs were often found in neighboring astrocytes that were filled with GFAP but did not contain RFs (Fig. 6a and b; Additional file 2: Figure S4b). It is worth noting that the resolution of confocal microscopy and the staining properties of FJB and DAPI may not allow us to visualize the smallest RF seen in the electron microscope. But even considering this possibility the difference between neighboring astrocytes is striking. Variability in RF shapes and size was regularly observed, and even adjacent astrocytes often differed in the shapes and sizes of RFs (Fig. 1c, Additional files 5 and 6: Movie 1 and 1a, Additional file 2: Figure S4b, c).
RFs accumulate and enlarge with age
To assess the appearance of RFs with age, we compared RFs in 1 month and 1 year old TG and KI mouse cortex with FJB and found a significant increase in the numbers (for TG: 159.9 ± 17.8 RFs in 1 month old vs 406.9 ± 48.7 in 1 year old mice per 12,155 μm2, P = 0.005; for KI: 65.4 ± 15.6 in 1 month old vs 186.0 ± 33.7 in 1 year old mice per 12,155 μm2, P = 0.008) and sizes of RFs (in TG in 1 month old mice the average size of RFs was 3.03 ± 0.6 μm2 vs 41.9 ± 2.8 μm2 in 1 year old mice P = 0.008 and in KI in 1 month old mice the average size of RFs was 2.25 ± 0.2 μm2 vs 3.36 ± 0.26 μm2 in 1 year old mice P = 0.008), indicating the continuous formation and enlargement of RFs with time in both lines of mice. These data are in line with previous results  that TG mice reveal more severe pathology compared to KI mice.
Accumulation of RFs correlates with changes in astrocyte phenotype
The prominent feature of the astrocytes with lobulated and large nuclei in the KI homozygous mice should be noted. They often contained GFAP+ spots in the nuclei that looked like intranuclear inclusions (Fig. 7b1). These were extremely rare in TG and double mutant mice. Analysis of the 3D structure of such nuclei with confocal microscopy and of their ultrastructure revealed that these GFAP+’inclusions’ were RFs located in deep cytoplasmic invaginations of nuclei (Fig. 7b, c), hence “pseudoinclusions”.
We have proposed  that nuclear changes in abnormal astrocytes might be caused by arrested mitoses. To look for any spatial relationships between RFs and chromosomes during mitosis, we examined the hippocampi of 1 week-old double mutant mice, which show high astrocyte mitotic activity . We found that RFs in mitotic astrocytes were located between metaphase chromosomes (Fig. 8a; Additional files 10, 11 and 12: Movie 5, 5a, 5b). This localization of RFs suggested that the inclusions caused chromosome misalignment, possibly resulting in mitotic arrest. We examined astrocytes with Ki67+ nuclei that appeared abnormal (highly undulated or with several micronuclei). These astrocytes also contained large numbers of RFs (Additional file 13: Figure S5; Additional files 14 and 15: Movie 6 and 6a). Based on all of these observations we conclude that RFs may participate in abnormal chromosomal segregation and cause mitotic abnormalities and/or mitotic arrest.
Additional file 12: Movie 5b. (AVI 4315 kb)
We examined autopsy brain tissues from two patients with AxD and found nuclear pathology similar to that in mouse astrocytes. Many astrocytes had loosely-distributed metaphase chromosomes (corresponding to arrested in metaphase mitoses) intermingled with RF in enlarged bodies (Fig. 8b). Some astrocytes had nuclei with pseudoinclusions, i.e. eosinophilic and GFAP+ material of RFs within nuclei (Fig. 8c and e). Multinucleated astrocytes with several nuclei and RFs were also common findings (Fig. 8d and f).
Many astrocytes in every strain showed enlarged cell bodies and nuclei, which may indicate polyploidy . To assess this possibility we examined the numbers of centrosomes and found multiple centrosomes per cell, indicating that these astrocytes had undergone mitosis without cytokinesis (Additional file 16: Figure S6). We have previously shown multiple centrosomes in abnormal astrocytes in the double mutant mice .
In this study we examined four different strains of AxD mutant mice at three different ages to observe stages of RF formation. At all times and in all lines of the mice we found a high degree of variability in the sizes and shapes of RFs. The appearance of RFs ranged from large, dense structures to small, less dense structures that appeared to be deposited on intermediate filaments. We also found that DAPI was an excellent marker for RFs, allowing us to view the distributions of RFs.
How do RFs form?
Immuno-electron microscopy showed that the granular electron-dense material contains both alphaB-crystallin and GFAP. We did not look for other RF proteins in the smallest aggregates, however, and other proteins may be there as well and may be important in RF formation. Nevertheless, since alphaB-crystallin binds to GFAP , these two proteins could be sufficient to form aggregates. The small, granular material attached to filaments contains GFAP and alphaB-crystallin . Thus, one possible mechanism underlying RF formation is the binding of alphaB-crystallin to wild type and/or mutant GFAP monomers or oligomers, which then can associate with filaments. Aggregation into RFs is likely to be a phenomenon dependent upon protein concentration and the stoichiometry of GFAP and alphaB-crystallin levels. We previously found that overexpressing alphaB-crystallin in cultured astrocytes with normal GFAP levels debundled intermediate filaments, but did not depolymerize them or lead to the formation of RFs .
However, genetically overexpressing alphaB-crystallin in astrocytes in AxD mice reduced the oxidative stress response, RFs, seizures, and restored astrocyte glutamate uptake (). We do not know the stoichiometry of GFAP and alphaB-crystallin in individual astrocytes in either the AxD mice or in the AxD mice that overexpressed alphaB-crystallin. The alphaB-crystallin transgenics produce more alphaB-crystallin from the outset, a state somewhat different from AxD itself, and which might alter RF formation from the beginning.
Whether proteolytic degradation of GFAP plays a role in RF formation is not known. We previously performed Western blots of mouse AxD model brains and observed only a small band of GFAP- immunoreactive material migrating more rapidly than the main protein band, indicating a minimum level of GFAP proteolysis. Western blots, however, do show a series of less rapidly migrating bands, which are likely to represent ubiquitinated GFAP and GFAP oligomers [32–34]. However, Chen et al.  present evidence that GFAP is a substrate for caspase 6 and using an antibody to the cleaved peptide, found proteolyzed GFAP in cultured cells that expressed the R239H GFAP mutation and in the heterozygous KI mice. The small, 26 kDa fragment is largely insoluble, using a deoxycholate and Triton X-100 buffer, and thus it is possible that this fragment might be found in RFs and contribute to their formation.
Mouse RFs appear identical to human RFs
The idea that RFs are formed from an accumulation of smaller inclusions is consistent with reports of human biopsy and autopsy material. Thus, EM reports of human AxD note small RF-like material at the borders of larger RFs [1, 10, 19, 23]. Borrett and Becker (1985) reported a brain biopsy from a 14 week-old infant, which showed many small RFs in a bed of intermediate filaments, and concluded that these inclusions represented early RFs. We have observed the same small RFs in many of the mouse astrocytes. A biopsy of a 34 month-old child, described in the same report, showed a large RF and also several smaller ones within the large skein of filaments (see Fig. 6 in ). Variation in the size of RFs within a single astrocyte was also reported by Schochet et al. , who reported ultrastructural findings in an 8 month-old child showing a spectrum of sizes of RFs, including many small ones. RFs were connected to each other by filaments and granular material. Astrocytes in adult forms of AxD also show variation in the sizes of RFs with small inclusions situated among the larger ones [25, 29]. Neuropathologists have not previously commented on the small, granular profiles or the less dense matrix of small RFs, although Herndon et al.  commented on the “thickening” of filaments in the vicinity of a RF (their Fig. 13), and granular deposits on the filaments. Of course, nothing was known about the molecular composition of RFs at that time.
RFs can form anywhere in the astrocyte and continue to form over time
The presence of small RFs in all parts of the astrocyte, including cell body, processes, and endfeet, suggests that RFs can be independently formed throughout the cell, although we cannot rule out the possibility that some form in the cell body and are then transported to endfeet.
RFs continue to be generated over time in parallel with the accumulation of GFAP. We observed the small, electron dense aggregates in 1 month-old as well as in 1 year-old AxD mice. Although at every timepoint there was a large degree of variability in RF size, the numbers and sizes of RFs were greater in the older mice. Thus, RF formation is an ongoing process in AxD, rather than just occurring at early stages of the disorder.
However, even in the areas with high levels of astrogliosis not every astrocyte contained RFs. We were surprised that some astrocytes filled with GFAP did not contain RFs, whereas nearby astrocytes contained many RFs. Different levels of alphaB-crystallin and/or some other heat shock proteins that participate in RF formation might be responsible for the variable numbers of RFs in astrocytes. We could not exclude the possibility, however, that the very small RFs (200–300 nm in size) seen with the electron microscope are below the resolution of the confocal microscope.
Do RFs influence astrocyte phenotype?
Do RFs influence astrocyte phenotype or are they innocuous structures that have no effects on cell morphologies or functions? Given that RFs are always located within large skeins of intermediate filaments, it is difficult to dissect clearly the effects of RFs per se from those of the filament accumulations. Indeed, some changes of astrocytes, such as the new expression of CD44, do not depend on the presence of RFs, since high levels of CD44 were observed in cells with and without RFs. A similar case is true for other markers of astrocytes that we used (GLT-1, GLAST, ferritin, Kir 4.1, vimentin, nestin, not shown).
The two prominent changes that were consistently associated with large numbers of RFs were 1) a thickening and shortening of main processes and a loss of miniature leaf-like processes, and 2) abnormalities in nuclear morphologies. Astrocytes retract many of their processes during arrested mitoses and then extend them to their normal size after slippage from mitotic arrest (manuscript in preparation). Astrocytes filled with RFs may not be able to restore the normal shapes and sizes of their processes, presumably due to a disruption of proper cytoskeletal orientation by RFs. A loss of small, distal processes may have special significance because distal processes that isolate synapses are responsible for extraneuronal ion and transmitter homeostasis. Their absence might severely alter neuronal excitability [12, 18]. Note that the double mutant AxD mice develop seizures at 4-5 weeks of age. Transgenic and KI AxD mice are more susceptible to kainic acid-induced seizures compared to wild type mice [7, 31]. Those astrocytes that displayed such changes also showed enlargement and irregular forms of nuclei. We consider that the nuclear abnormalities originate due to arrested mitosis when RFs interfere with chromosome congression into the metaphase plate and subsequent segregation into two daughter groups, not allowing cells to fulfill cytokinesis. Finding RFs in mitotic astrocytes in mouse and in human indicates that at least some RFs do not depolymerize during mitosis. RFs between chromosomes would likely interfere with normal chromosome segregation and spindle formation. In addition, the formation of the nuclear envelope in telophase may also be influenced by RFs. Filaments are bound by the cytoskeleton linker protein plectin to nesprin-3, located in outer leaflet of the nuclear envelope . Plectin accumulates in RFs , and thus could link RFs to the nuclear envelope and interfere with the formation or dissolution of the nuclear envelope.
We also observed that RFs with associated filament bundles often excluded membranous organelles, segregating those organelles either to a paranuclear position or to the periphery of the cell. In cultures of AxD astrocytes, we found separation of Golgi and ER complexes and fragmentation of the Golgi apparatus by large bundles of filaments and RFs (Guilfoyle and Sosunov, unpublished). These observations suggest that membrane trafficking may be disrupted in AxD astrocytes. RFs may increase the mechanical stability of filament bundles/aggregates and thus create mechanical barriers for intracellular trafficking as well for chromosome congression and segregation during mitosis.
DAPI as a new method for visualizing RFs
We found that DAPI can be used as a reliable and reproducible method of visualizing RFs. An advantage of this method is the ability to combine it with routine immunohistochemical procedures. Why RFs are stained with DAPI is not clear. One possible explanation may be that DAPI, like FJB, has an affinity for highly acidic structures. Fluorescent Nissl Stain (Neuro Trace, Molecular Probes) also gives positive staining of RFs (unpublished results) but in comparison with DAPI is much less reproducible and does not stain the small puncta-like RFs.
RFs appear to originate as small, osmiophilic masses containing both GFAP and alphaB-crystallin deposited on bundles of intermediate filaments.
RFs continue to form within AxD astrocytes over time.
DAPI is a reliable marker for RFs and can be used with immunolabeling.
RFs and bundles of filaments appear to interfere with the successful completion of astrocyte mitosis.
Fluoro jade B
Glial fibrillary acidic protein
The authors thank Markel Olabarria and Eileen Guilfoyle for their discussions and comments.
The study was funded in part by the Tuberous Sclerosis Alliance and NIH PO1NS042803
Availability of data and material
All data generated or analyzed during this study are included in this published article [and its supplementary information files].
AS and JEG designed the study, AS performed the histological and immunocytochemical examinations, AS and JEG wrote the manuscript; All authors edited, read, and approved the manuscript.
The authors declare that they have no competing interests.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
- Borrett D, Becker LE (1985) Alexander’s disease. A disease of astrocytes. Brain 108(Pt 2):367–385View ArticlePubMedGoogle Scholar
- Chen MH, Hagemann TL, Quinlan RA, Messing A, Perng MD (2013) Caspase cleavage of GFAP produces an assembly-compromised proteolytic fragment that promotes filament aggregation. ASN Neuro 5:e00125. doi:10.1042/AN20130032 View ArticlePubMedPubMed CentralGoogle Scholar
- Colombo JA, Puissant VI (2002) Fluoro Jade stains early and reactive astroglia in the primate cerebral cortex. J Histochem Cytochem 50:1135–1137View ArticlePubMedGoogle Scholar
- Cyrine S, Sonia Z, Mounir T, Badderedine S, Kalthoum T, Hedi K, Moncef M (2013) Pilocytic astrocytoma: a retrospective study of 32 cases. Clin Neurol Neurosurg 115:1220–1225. doi:10.1016/j.clineuro.2012.11.009 View ArticlePubMedGoogle Scholar
- Der Perng M, Su M, Wen SF, Li R, Gibbon T, Prescott AR, Brenner M, Quinlan RA (2006) The Alexander disease-causing glial fibrillary acidic protein mutant, R416W, accumulates into Rosenthal fibers by a pathway that involves filament aggregation and the association of alpha B-crystallin and HSP27. Am J Hum Genet 79:197–213. doi:10.1086/504411 View ArticlePubMed CentralGoogle Scholar
- Hagemann TL, Boelens WC, Wawrousek EF, Messing A (2009) Suppression of GFAP toxicity by alphaB-crystallin in mouse models of Alexander disease. Hum Mol Genet 18:1190–1199. doi:10.1093/hmg/ddp013 View ArticlePubMedPubMed CentralGoogle Scholar
- Hagemann TL, Connor JX, Messing A (2006) Alexander disease-associated glial fibrillary acidic protein mutations in mice induce Rosenthal fiber formation and a white matter stress response. J Neurosci 26:11162–11173. doi:10.1523/JNEUROSCI.3260-06.2006 View ArticlePubMedGoogle Scholar
- Head MW, Hurwitz L, Kegel K, Goldman JE (2000) AlphaB-crystallin regulates intermediate filament organization in situ. Neuroreport 11:361–365View ArticlePubMedGoogle Scholar
- Heaven MR, Flint D, Randall SM, Sosunov AA, Wilson L, Barnes S, Goldman JE, Muddiman DC, Brenner M (2016) Composition of Rosenthal fibers, the protein aggregate hallmark of Alexander disease. J Proteome Res 15:2265–2282. doi:10.1021/acs.jproteome.6b00316 View ArticlePubMedGoogle Scholar
- Herndon RM, Rubinstein LJ, Freeman JM, Mathieson G (1970) Light and electron microscopic observations on Rosenthal fibers in Alexander’s disease and in multiple sclerosis. J Neuropathol Exp Neurol 29:524–551View ArticlePubMedGoogle Scholar
- Jay V, Edwards V, Rutka J, Mosskin M, Hwang P, Resch L (1998) Unique desmoplastic cerebral tumor in a patient with complex partial seizures. Pediatr Dev Patho 1:234–242View ArticleGoogle Scholar
- Kacerovsky JB, Murai KK (2016) Stargazing: monitoring subcellular dynamics of brain astrocytes. Neuroscience 323:84–95. doi:10.1016/j.neuroscience.2015.07.007 View ArticleGoogle Scholar
- Khanlou N, Mathern GW, Mitchell WG, Salamon N, Pope WB, Yong WH, Vinters HV (2009) Cortical dysplasia with prominent Rosenthal fiber formation in a case of intractable pediatric epilepsy. Hum Pathol 40:1200–1204. doi:10.1016/j.humpath.2009.02.012 View ArticlePubMedGoogle Scholar
- Kupsky WJ, Frosch M (1993) Tuberous sclerosis variant with production of Rosenthal fibers (alpha B-crystallin). Pediatr Pathol 13:869–873View ArticlePubMedGoogle Scholar
- Li R, Messing A, Goldman JE, Brenner M (2002) GFAP mutations in Alexander disease. Int Dev Neurosci 20:259–268View ArticleGoogle Scholar
- Messing A, Head MW, Galles K, Galbreath EJ, Goldman JE, Brenner M (1998) Fatal encephalopathy with astrocyte inclusions in GFAP transgenic mice. Am J Pathol 152:391–398PubMedPubMed CentralGoogle Scholar
- Minkel HR, Anwer TZ, Arps KM, Brenner M, Olsen ML (2015) Elevated GFAP induces astrocyte dysfunction in caudal brain regions: A potential mechanism for hindbrain involved symptoms in type II Alexander disease. Glia 63:2285–2297. doi:10.1002/glia.22893 View ArticlePubMedPubMed CentralGoogle Scholar
- Olabarria M, Goldman JE (2017) Disorders of astrocytes: Alexander disease as a model. Annu Rev Pathol 12:131–152. doi:10.1146/annurev-pathol-052016-100218 View ArticlePubMedGoogle Scholar
- Peiffer J (1968) Alexander’s disease--really a leucodystrophy? Pathol Eur 3:305–312PubMedGoogle Scholar
- Pekny T, Faiz M, Wilhelmsson U, Curtis MA, Matej R, Skalli O, Pekny M (2014) Synemin is expressed in reactive astrocytes and Rosenthal fibers in Alexander disease. APMIS 122:76–80. doi:10.1111/apm.12088 View ArticlePubMedGoogle Scholar
- Quinlan RA, Brenner M, Goldman JE, Messing A (2007) GFAP and its role in Alexander disease. Exp Cell Res 313:2077–2087. doi:10.1016/j.yexcr.2007.04.004 View ArticlePubMedPubMed CentralGoogle Scholar
- Schmued LC, Hopkins KJ (2000) Fluoro-Jade B: a high affinity fluorescent marker for the localization of neuronal degeneration. Brain Res 874:123–130View ArticlePubMedGoogle Scholar
- Schochet SS Jr, Lampert PW, Earle KM (1968) Alexander’s disease. A case report with electron microscopic observations. Neurology 18:543–549View ArticlePubMedGoogle Scholar
- Schoenfelder KP, Fox DT (2015) The expanding implications of polyploidy. J Cell Biol 209:485–491. doi:10.1083/jcb.201502016 View ArticlePubMedPubMed CentralGoogle Scholar
- Seil FJ, Schochet SS Jr, Earle KM (1968) Alexander’s disease in an adult. Rep Case Arch Neurol 19:494–502View ArticleGoogle Scholar
- Smith DA, Lantos PL (1985) Immunocytochemistry of cerebellar astrocytomas: with a special note on Rosenthal fibres. Acta Neuropathol 66:155–159View ArticlePubMedGoogle Scholar
- Sonnenberg A, Liem RK (2007) Plakins in development and disease. Exp Cell Res 313:2189–2203. doi:10.1016/j.yexcr.2007.03.039 View ArticlePubMedGoogle Scholar
- Sosunov AA, Guilfoyle E, Wu X, McKhann GM 2nd, Goldman JE (2013) Phenotypic conversions of “protoplasmic” to “reactive” astrocytes in Alexander disease. J Neurosci 33:7439–7450. doi:10.1523/JNEUROSCI.4506-12.2013 View ArticlePubMedPubMed CentralGoogle Scholar
- Spalke G, Mennel HD (1982) Alexander’s disease in an adult: clinicopathologic study of a case and review of the literature. Clin Neuropathol 1:106–112PubMedGoogle Scholar
- Tanaka KF, Ochi N, Hayashi T, Ikeda E, Ikenaka K (2006) Fluoro-Jade: new fluorescent marker of Rosenthal fibers. Neurosci Lett 407:127–130. doi:10.1016/j.neulet.2006.08.014 View ArticlePubMedGoogle Scholar
- Tanaka KF, Takebayashi H, Yamazaki Y, Ono K, Naruse M, Iwasato T, Itohara S, Kato H, Ikenaka K (2007) Murine model of Alexander disease: analysis of GFAP aggregate formation and its pathological significance. Glia 55:617–631. doi:10.1002/glia.20486 View ArticlePubMedGoogle Scholar
- Tang G, Perng MD, Wilk S, Quinlan R, Goldman JE (2010) Oligomers of mutant glial fibrillary acidic protein (GFAP) Inhibit the proteasome system in alexander disease astrocytes, and the small heat shock protein alphaB-crystallin reverses the inhibition. J Biol Chem 285:10527–10537. doi:10.1074/jbc.M109.067975 View ArticlePubMedPubMed CentralGoogle Scholar
- Tang G, Xu Z, Goldman JE (2006) Synergistic effects of the SAPK/JNK and the proteasome pathway on glial fibrillary acidic protein (GFAP) accumulation in Alexander disease. J Biol Chem 281:38634–38643. doi:10.1074/jbc.M604942200 View ArticlePubMedGoogle Scholar
- Tang G, Yue Z, Talloczy Z, Hagemann T, Cho W, Messing A, Sulzer DL, Goldman JE (2008) Autophagy induced by Alexander disease-mutant GFAP accumulation is regulated by p38/MAPK and mTOR signaling pathways. Hum Mol Genet 17:1540–1555. doi:10.1093/hmg/ddn042 View ArticlePubMedPubMed CentralGoogle Scholar
- Tian R, Gregor M, Wiche G, Goldman JE (2006) Plectin regulates the organization of glial fibrillary acidic protein in Alexander disease. Am J Pathol 168:888–897. doi:10.2353/ajpath.2006.051028 View ArticlePubMedPubMed CentralGoogle Scholar
- Tomokane N, Iwaki T, Tateishi J, Iwaki A, Goldman JE (1991) Rosenthal fibers share epitopes with alpha B-crystallin, glial fibrillary acidic protein, and ubiquitin, but not with vimentin. Immunoelectron microscopy with colloidal gold. Am J Pathol 138:875–885PubMedPubMed CentralGoogle Scholar